Skip to content

Search for:
Home
About HubLE
Content
Webinars
Podcasts
IFMRS
Other
Menu

Duchenne Muscular Dystrophy

Lcn2 in the bone and muscle phenotype of the MDX mouse model of Duchenne muscular dystrophy

14 April 2022 Marco Ponzetti

Categories HubLE Publications Tags Basic, bone and muscle, Duchenne Muscular Dystrophy, Inflammation, Lipocalin-2

Growth hormone and/or testosterone trend to reduce vertebral fracture hazard risk in Duchenne muscular dystrophy on chronic glucocorticoids

23 February 202325 November 2021 Emely Loscalzo

Categories HubLE Exchange, Uncategorized Tags ASBMR, ASBMR 2021, clinical, Duchenne Muscular Dystrophy, glucocorticoid steroids, growth, muscle, puberty, testosterone, vertebral fracture

Search for:

Recent Posts

BoneUP Live @ECTS 2024 – IFMRS Interview
BoneUP Live @ECTS 2024 – ECTS Interview
IFMRS & HubLE Intro @ ANZBMS & KSBMR Joint Webinar
Addressing musculoskeletal conditions: an opportunity for health systems globally
Autoantibody mediated inflammation co-activates FcgR and IFNgR pathways in osteoclasts

Recent Comments

Diego Grinman on Site-specific alterations in murine osteocyte lacuno-canalicular network inflicted with osteotropic tumor cells
Diego on HubLE Advice by Professor Ego Seeman
Allison Pettit on For increase recognition for the importance of laboratory-based discovery research

Archives

Categories

Archive: HubLE Graphics
Future Global Leaders Webinars
HubLE Exchange
HubLE Graphics
HubLE Opinions
HubLE Publications
HubLE Resources
Podcasts
Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

CONTACT US
PRIVACY POLICY
DISCLAIMER

Menu

CONTACT US
PRIVACY POLICY
DISCLAIMER

© 2021-2023 – International Federation of Musculoskeletal Research Societies

Home
About HubLE
Content
Webinars
Podcasts
IFMRS
Other